SG1827

· Hangzhou Sumgen Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SG1827, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors [Phase 1]